Angiotensin converting enzyme (ACE) inhibitors have been introduced for the treatment of
heart failure within the last decade. Their potential value was suggested by studies showing …

Angiotensin‐converting enzyme (ACE) inhibitors have been used for more than a decade in
the treatment of chronic congestive heart failure. In recent years these agents have been …

OBJECTTVE: To discuss the controversies surrounding the choice of angiotensin-converting
enzyme (ACE) inhibitor, and the timing, dosage, and duration of ACE inhibitor therapy for …

Abstract Treatment with angiotensin converting enzyme (ACE) inhibitors delays deterioration
and improves survival in chronic congestive heart failure and left ventricular dysfunction. In …

Although the underlying pathophysiology in most patients with congestive heart failure is
impaired myocardial contractility, hemodynamic and clinical benefit can be achieved by …

We now have conclusive data that ACE inhibitors reduce mortality, morbidity, and symptoms
in patients with low ejection fraction and/or heart failure. Therefore, ACE inhibitors should be …

During the last decade, angiotensin-converting enzyme inhibitors (ACE-I) have become
cornerstones in the treatment of clinical congestive heart failure, there is convincing …

Angiotensin-converting enzyme inhibitors (ACE inhibitors) have been shown to be effective
in improving symptoms and survival in patients with systolic left ventricular dysfunction …

Discusses the appropriate setting for the use of angiotensin-converting enzyme (ACE)
inhibitor use after myocardial infarction and in congestive heart failure. Potential benefits of …

ACE inhibitors (ACEIs) have now been shown to improve symptoms and survival in patients
with mild, moderate and severe chronic heart failure. Their mechanism of action is thought to …